Endocrinology, Vol 123, 2341-2350, Copyright © 1988 by Endocrine Society

ARTICLES

Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine

AM Judd, IS Login, K Kovacs, PC Ross, BL Spangelo, WD Jarvis and RM MacLeod
Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville 22908.

Although dopamine inhibits PRL release from the normal anterior pituitary lactotroph, a conclusive demonstration of the mechanisms involved in this response has been impeded by the presence of other cell types in the anterior pituitary. To circumvent this problem, we have isolated a clonal cell line, designated MMQ, from the 7315a rat pituitary tumor. The MMQ cell is an exemplary model for our use because it only secretes PRL. Our studies show that dopamine inhibits secretagogue-induced PRL release from these cells. In addition, dopamine decreases the intracellular cAMP concentration in MMQ cells that have been exposed to forskolin, cholera toxin, or vasoactive intestinal polypeptide, each a stimulator of cAMP generation. This inhibition is, in turn, reversed by the dopamine antagonist haloperidol and by pertussis toxin, an inactivator of the GTP-binding coupling protein. Dopamine also decreases the uptake and fractional efflux of 45Ca2+ by MMQ cells that have been exposed to the calcium channel activator maitotoxin. It seems, therefore, that dopamine decreases PRL release from MMQ cells at least in part by decreasing intracellular cAMP levels and calcium uptake. In additional experiments, we have found that MMQ cells are responsive to somatostatin, estrogen, progesterone, and acetylcholine, but not to TRH, angiotensin II, neurotensin, or bombesin. Furthermore, these cells possess a functional protein kinase-C system, as evidenced by the increase in PRL release and decrease in stimulated intracellular cAMP levels that occur in response to treatment with phorbol diesters. We suggest that the MMQ cell line will prove a useful model system for study of the biochemical effects of dopamine and other factors that modify PRL release.

This article has been cited by other articles:

				K. Francis, B M. Lewis, P. N Monk, and J. Ham Complement C5a receptors in the pituitary gland: expression and function J. Endocrinol., December 1, 2008; 199(3): 417 - 424. [Abstract] [Full Text] [PDF]

				C. Cristina, G. Diaz-Torga, A. Baldi, A. Gongora, M. Rubinstein, M. J. Low, and D. Becu-Villalobos Increased Pituitary Vascular Endothelial Growth Factor-A in Dopaminergic D2 Receptor Knockout Female Mice Endocrinology, July 1, 2005; 146(7): 2952 - 2962. [Abstract] [Full Text] [PDF]

				D. Schausi, C. Tiffoche, and M.-L. Thieulant Regulation of the Intronic Promoter of Rat Estrogen Receptor {alpha} Gene, Responsible for Truncated Estrogen Receptor Product-1 Expression Endocrinology, July 1, 2003; 144(7): 2845 - 2855. [Abstract] [Full Text] [PDF]

				C. Iaccarino, T. A. Samad, C. Mathis, H. Kercret, R. Picetti, and E. Borrelli Control of lactotrop proliferation by dopamine: Essential role of signaling through D2 receptors and ERKs PNAS, October 29, 2002; 99(22): 14530 - 14535. [Abstract] [Full Text] [PDF]

				M. Lecchi, E. Redaelli, B. Rosati, G. Gurrola, T. Florio, O. Crociani, G. Curia, R. R. Cassulini, A. Masi, A. Arcangeli, et al. Isolation of a Long-Lasting eag-Related Gene-Type K+ Current in MMQ Lactotrophs and Its Accommodating Role during Slow Firing and Prolactin Release J. Neurosci., May 1, 2002; 22(9): 3414 - 3425. [Abstract] [Full Text] [PDF]

				C. Tiffoche, C. Vaillant, D. Schausi, and M.-L. Thieulant Novel Intronic Promoter in the Rat ER{alpha} Gene Responsible for the Transient Transcription of a Variant Receptor Endocrinology, September 1, 2001; 142(9): 4106 - 4119. [Abstract] [Full Text] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				G. B. GURROLA, B. ROSATI, M. ROCCHETTI, G. PIMIENTA, A. ZAZA, A. ARCANGELI, M. OLIVOTTO, L. D. POSSANI, and E. WANKE A toxin to nervous, cardiac, and endocrine ERG K+ channels isolated from Centruroides noxius scorpion venom FASEB J, May 1, 1999; 13(8): 953 - 962. [Abstract] [Full Text]

				D. Guivarc'h, J.-D. Vincent, and P. Vernier Alternative Splicing of the D2 Dopamine Receptor Messenger Ribonucleic Acid Is Modulated by Activated Sex Steroid Receptors in the MMQ Prolactin Cell Line Endocrinology, October 1, 1998; 139(10): 4213 - 4221. [Abstract] [Full Text] [PDF]

				U. Renner, T. Arzberger, U. Pagotto, S. Leimgruber, E. Uhl, A. Müller, M. Lange, A. Weindl, and G. K. Stalla Heterogenous Dopamine D2 Receptor Subtype Messenger Ribonucleic Acid Expression in Clinically Nonfunctioning Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1368 - 1375. [Abstract] [Full Text]

				B. L. Spangelo, D. D. Farrimond, M. Thapa, C. M. Bulathsinghala, K.-L. Bowman, A. Sareh, F. M. Hughes Jr., A. L. Goldstein, and M. Badamchian Thymosin Fraction 5 Inhibits the Proliferation of the Rat Neuroendocrine MMQ Pituitary Adenoma and C6 Glioma Cell Lines in Vitro Endocrinology, April 1, 1998; 139(4): 2155 - 2162. [Abstract] [Full Text] [PDF]

				T. A. Samad, W. Krezel, P. Chambon, and E. Borrelli Regulation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family PNAS, December 23, 1997; 94(26): 14349 - 14354. [Abstract] [Full Text] [PDF]

				J. R. Wu-Wong, D. B. Dixon, W. J. Chiou, and T. J. Opgenorth Endothelin Receptor Antagonists: Effect of Serum Albumin on Potency and Comparison of Pharmacological Characteristics J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 791 - 798. [Abstract] [Full Text]

				C. Lavalle, A. Graef, V. Baca, M. Ramirez-Lacayo, F. Blanco-Favela, and O. Ortiz Review: Prolactin and Gonadal Hormones: A Key Relationship That May Have Clinical, Monitoring and Therapeutic Implications in Systemic Lupus Erythematosus Lupus, April 1, 1993; 2(2): 71 - 75. [PDF]

				E S Klein, D M Simmons, L W Swanson, and M G Rosenfeld Tissue-specific RNA splicing generates an ankyrin-like domain that affects the dimerization and DNA-binding properties of a bHLH protein. Genes & Dev., January 1, 1993; 7(1): 55 - 71. [Abstract] [PDF]